News & Announcements

DIABETOLOGY LTD | BONE MEDICAL LTD | KANCER LTD

Phase IIa Trial on Oral Insulin product Capsulin™ in Type 1 Diabetics Successful

Diabetology Ltd is pleased to announce the positive completion of phase IIa trial

Click Here for Details

Successful Phase I Study on Oral Insulin product Capsulin™ in healthy volunteers

Diabetology Ltd is pleased to announce the positive completion of phase I trial

Click Here for Details

Back to top

Progress with Arthritis Drug Candidate

Bone Medical Medical (ASX:BNE) Announcement: July 2005

Click Here for Details

Perthoxal™ Trial News

Bone Medical Limited (ASX:BNE) Completes Perthoxal™ Trial

Click Here for Details

Bone Announces Success: Pre-Clinical Trials

Bone Medical Limited (ASX:BNE) announces successful pre-clinical trial results for oral therapeutics to treat rheumatoid arthritis

Click Here for Details

Positive Phase I/IIa Clinical Trial on Oral Osteoporosis Drug

Bone Medical Limited (ASX:BNE) is pleased to announce the positive completion of the first human clinical testing of its oral calcitonin osteoporosis drug, BN002

Click Here for Details

Bone completes phase one human trial

Biopharmaceutical development company Bone Ltd said it has successfully completed the human phase one component for its oral calcitonin product, BN002.

Click Here for Details

Bone strikes elite research alliance ahead of ASX listing

Bone Medical Limited is pleased to announce it has entered into a Collaborative Testing Agreement with the Institute of Bone and Joint Research (IBJR)

Click Here for Details

Back to top

Website under maintenance

For more information please go to Kancer Ltd website: www.kancer.co.uk

Back to top